ALEXIS ADEOJO: Open Payments
NPI 1336823095 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,543 in 101 payments from 18 companies in 2025. Trend: 2023 $164 · 2024 $1,132 · 2025 $2,543
Food & beverage: $2,492Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $345 |
| Gilead Sciences, Inc. | 5 | $305 |
| Janssen Biotech, Inc. | 9 | $294 |
| Madrigal Pharmaceuticals | 8 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $171 |
| Ardelyx, Inc. | 5 | $167 |
| Aimmune Therapeutics, Inc. | 3 | $158 |
| PFIZER INC. | 10 | $140 |
| Lilly USA, LLC | 6 | $139 |
| QOL Medical, LLC | 4 | $115 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, ENTYVIO, ZENPEP, OMVOH, RINVOQ, DUPIXENT.
Industry payments across GA — which companies pay providers there.
